I2526
Insulin-like Growth Factor-II human
IGF-II, recombinant, expressed in E. coli, lyophilized powder, suitable for cell culture
Manufacturer: Sigma Aldrich
Synonym(S): IGF-II
Select a Size
| Pack Size | SKU | Availability | Price |
|---|---|---|---|
| 50 μG | I2526-50-μG | In Stock | ₹ 29,790.40 |
I2526 - 50 μG
In Stock
Quantity
1
Base Price: ₹ 29,790.40
GST (18%): ₹ 5,362.272
Total Price: ₹ 35,152.672
biological source
human
Quality Level
200
recombinant
expressed in E. coli
Assay
≥98% (SDS-PAGE and HPLC)
form
lyophilized powder
potency
≤2.0 ng/mL ED50
quality
endotoxin tested
mol wt
7.5 kDa
packaging
pkg of 5X50 μgpkg of 50 μg
technique(s)
cell culture | mammalian: suitable
Related Products
Description
- Biochem/physiol Actions: Insulin-like growth factor II (IGF-II) also known as multiplication stimulating activity (MSA), shows virtually identical bioactivities as IGF-I. Expression of IGF-II is highest in fetal tissues, where it is believed to play a major role in overall growth and development. After birth IGF-II expression decreases to much lower levels in a variety of tissues. IGF-II is produced also in several tumors. IGF-II binds to IGF-II receptor (IGF-IIR), to IGF-IR and weakly to the insulin receptor (IR). All IGF-II bioactivities in adult tissues are generally attributed to its interaction with IGF-IR. However, during embryogenesis the roles of both IGF-IIR and IR may be significant in promoting normal growth.
- Physical form: Lyophilized from a 0.2 μm filtered solution with no additives.
- Analysis Note: The biological activity is measured by a cell proliferation assay using mouse FDC-P1
SAFETY INFORMATION
WGK
WGK 3
Flash Point(F)
Not applicable
Flash Point(C)
Not applicable
Personal Protective Equipment
dust mask type N95 (US), Eyeshields, Gloves
Compare Similar Items
Show Difference
biological source: human
Quality Level: 200
recombinant: expressed in E. coli
Assay: ≥98% (SDS-PAGE and HPLC)
form: lyophilized powder
potency: ≤2.0 ng/mL ED50
quality: endotoxin tested
mol wt: 7.5 kDa
packaging: pkg of 5X50 μgpkg of 50 μg
technique(s): cell culture | mammalian: suitable
biological source:
human
Quality Level:
200
recombinant:
expressed in E. coli
Assay:
≥98% (SDS-PAGE and HPLC)
form:
lyophilized powder
potency:
≤2.0 ng/mL ED50
quality:
endotoxin tested
mol wt:
7.5 kDa
packaging:
pkg of 5X50 μgpkg of 50 μg
technique(s):
cell culture | mammalian: suitable
biological source: human
Quality Level: 200
recombinant: expressed in yeast (proprietary host)
Assay: ≥98% (HPLC)
form: powder
potency: ≥27.5 units/mg (dried basis)
quality: __
mol wt: __
packaging: __
technique(s): cell culture | mammalian: suitable
biological source:
human
Quality Level:
200
recombinant:
expressed in yeast (proprietary host)
Assay:
≥98% (HPLC)
form:
powder
potency:
≥27.5 units/mg (dried basis)
quality:
__
mol wt:
__
packaging:
__
technique(s):
cell culture | mammalian: suitable
biological source: human
Quality Level: 200
recombinant: expressed in E. coli
Assay: __
form: lyophilized powder
potency: ≤700 EC50
quality: endotoxin tested
mol wt: 15.5 kDa
packaging: pkg of 5X10 μgpkg of 10 μg
technique(s): cell culture | mammalian: suitable
biological source:
human
Quality Level:
200
recombinant:
expressed in E. coli
Assay:
__
form:
lyophilized powder
potency:
≤700 EC50
quality:
endotoxin tested
mol wt:
15.5 kDa
packaging:
pkg of 5X10 μgpkg of 10 μg
technique(s):
cell culture | mammalian: suitable
biological source: __
Quality Level: __
recombinant: __
Assay: 99%
form: __
potency: __
quality: __
mol wt: __
packaging: __
technique(s): __
biological source:
__
Quality Level:
__
recombinant:
__
Assay:
99%
form:
__
potency:
__
quality:
__
mol wt:
__
packaging:
__
technique(s):
__